FOXD4L1
Basic information
Region (hg38): 2:113498665-113501150
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXD4L1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 3 | 0 |
Variants in FOXD4L1
This is a list of pathogenic ClinVar variants found in the FOXD4L1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-113499278-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
2-113499293-C-G | not specified | Uncertain significance (Jan 28, 2025) | ||
2-113499336-T-C | not specified | Uncertain significance (Jun 09, 2022) | ||
2-113499344-C-G | not specified | Uncertain significance (Jan 16, 2024) | ||
2-113499356-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
2-113499365-G-C | not specified | Uncertain significance (Jan 04, 2024) | ||
2-113499383-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
2-113499425-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
2-113499477-T-A | not specified | Uncertain significance (Apr 04, 2024) | ||
2-113499486-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
2-113499513-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
2-113499538-G-T | not specified | Uncertain significance (Oct 10, 2023) | ||
2-113499549-C-T | not specified | Uncertain significance (May 06, 2022) | ||
2-113499573-C-A | not specified | Uncertain significance (May 04, 2023) | ||
2-113499595-C-G | not specified | Uncertain significance (Sep 17, 2021) | ||
2-113499677-T-C | not specified | Uncertain significance (Feb 17, 2024) | ||
2-113499686-T-C | not specified | Uncertain significance (May 23, 2023) | ||
2-113499704-G-A | not specified | Uncertain significance (Feb 07, 2025) | ||
2-113499719-A-G | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
2-113499755-A-C | not specified | Uncertain significance (Mar 21, 2023) | ||
2-113499760-C-G | not specified | Uncertain significance (Nov 10, 2022) | ||
2-113499780-C-G | not specified | Uncertain significance (Feb 25, 2025) | ||
2-113499783-G-C | not specified | Uncertain significance (Nov 25, 2024) | ||
2-113499792-C-A | Likely benign (-) | |||
2-113499859-G-C | not specified | Uncertain significance (Aug 02, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FOXD4L1 | protein_coding | protein_coding | ENST00000306507 | 1 | 2068 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00766 | 0.794 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.316 | 251 | 237 | 1.06 | 0.0000111 | 2537 |
Missense in Polyphen | 63 | 64.011 | 0.9842 | 718 | ||
Synonymous | 0.150 | 105 | 107 | 0.982 | 0.00000520 | 928 |
Loss of Function | 0.990 | 4 | 6.78 | 0.590 | 3.00e-7 | 71 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.0795
Intolerance Scores
- loftool
- 0.217
- rvis_EVS
- 1.62
- rvis_percentile_EVS
- 95.96
Haploinsufficiency Scores
- pHI
- 0.0580
- hipred
- hipred_score
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0160
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;anatomical structure morphogenesis;cell differentiation
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;sequence-specific DNA binding